Browse

Home
People
Departments & Colleges
Research
Research Area Overlaps

BMC cancer Journal

Overview

Overview

publication venue for

Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts. 5:2. 2005

About

©2025 VIVO Project | Terms of Use | Powered by VIVO and the Web of Science (© 2025 Clarivate Analytics)